Zobrazeno 1 - 10
of 331
pro vyhledávání: '"S. Eridani"'
Publikováno v:
Cytotechnology. 1(1)
In classical t(9;22) translocation, as observed in chronic granulocytic leukemia (CGL), a hybrid DNA unit is produced, including a rearranged PHL gene, previously known as bcr (breakpoint cluster region) plus the translocated c-abl gene from chromoso
Autor:
S. Eridani, W. Paukovits
Publikováno v:
Cytotechnology. 2(Suppl 3)
Autor:
E. Abood, S. Eridani
Publikováno v:
Cytotechnology. 5:147-151
Autor:
S, Eridani
Publikováno v:
Cytotechnology. 35(2)
Both embryonic and somatic stem cells have been studied in recent years with particular regard to their differentiation potential. In vitro studies allow a considerable amplification of such cells in culture as well as the induction of commitment in
Publikováno v:
British Journal of Haematology. 75:188-194
Forty adult subjects were studied with the aim of establishing positive diagnostic criteria in primary proliferative polycythaemia (polycythaemia vera, PPP). These comprised 14 patients with PPP, eight secondary polycythaemia (SP), five idiopathic er
Publikováno v:
Biotherapy (Dordrecht, Netherlands). 11(4)
Human pluripotential stem cells (PSC) are currently the target for transplantation attempts and genetic manipulation. We have therefore investigated the frequency and the expansion potential of PSC's in different types of blood samples. CD 34+ cells
Publikováno v:
Haematologica. 79(4)
Primary proliferative polycythemia is a clonal disease characterized by excessive hemopoiesis and associated with a lower than normal erythropoietin plasma level; in vitro colony studies may reveal increased sensitivity of the abnormal clone to hemop
Autor:
S, Eridani
Publikováno v:
Haematologica. 78(6)
Increasing evidence for pathological erythroid clones and availability of additional diagnostic criteria suggest to reconsider the classification of polycythemia, with particular regard to the separation between primary proliferative polycythemia (PP
Autor:
A, Pagliuca, G J, Mufti, M, Janossa-Tahernia, S, Eridani, N B, Westwood, J, Thumpston, B, Sawyer, R, Sturgess, R, Williams
Publikováno v:
The Quarterly journal of medicine. 76(281)
We have studied the prevalence of an underlying myeloproliferative state in 20 patients with either hepatic or portal vein thrombosis. Using conventional clinical and laboratory criteria, an underlying myeloproliferative state was identified as the c
Autor:
Nigel Westwood, R.P. Sturgess, A Pagliuca, M. Janossa-Tahernia, Ghulam J. Mufti, B. Sawyer, Roger Williams, J. Thumpston, S. Eridani
Publikováno v:
QJM: An International Journal of Medicine.
We have studied the prevalence of an underlying myeloproliferative state in 20 patients with either hepatic or portal vein thrombosis. Using conventional clinical and laboratory criteria, an underlying myeloproliferative state was identified as the c